In dense urban communities, infection spread risk is extremely high. With the enormous effort in the scientific research community on verifying plant-derived, infectiousness-reducing therapeutics for covid, once there is a clinical trial hit, how will those medicinals be locally cultivated in sufficient quantity to more quickly reach the hands of the urban dwellers who need them most?